| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Jun 05, 2026 | Conversion | - | 40,000 | - | 923,735 | Jun 05, 2026, 05:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Jun 05, 2026 | Sale | $3.62 | 40,000 | 144,800 | 883,735 | Jun 05, 2026, 05:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | May 22, 2026 | Conversion | - | 40,000 | - | 923,735 | May 27, 2026, 04:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | May 22, 2026 | Sale | $3.08 | 40,000 | 123,200 | 883,735 | May 27, 2026, 04:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | May 15, 2026 | Tax Payment (Shares) | $3.04 | 22,821 | 69,376 | 883,735 | May 19, 2026, 05:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | May 07, 2026 | Conversion | - | 60,000 | - | 966,556 | May 08, 2026, 04:59 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | May 07, 2026 | Gift | - | 20,000 | - | 906,556 | May 08, 2026, 04:59 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | May 07, 2026 | Sale | $3.37 | 40,000 | 134,800 | 926,556 | May 08, 2026, 04:59 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Apr 22, 2026 | Conversion | - | 40,000 | - | 946,556 | Apr 24, 2026, 04:23 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Apr 22, 2026 | Sale | $3.61 | 40,000 | 144,400 | 906,556 | Apr 24, 2026, 04:23 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Apr 07, 2026 | Conversion | - | 40,000 | - | 946,556 | Apr 08, 2026, 04:58 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Apr 07, 2026 | Sale | $3.10 | 40,000 | 124,000 | 906,556 | Apr 08, 2026, 04:58 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Mar 23, 2026 | Conversion | - | 40,000 | - | 946,556 | Mar 25, 2026, 04:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Mar 23, 2026 | Sale | $3.25 | 40,000 | 130,000 | 906,556 | Mar 25, 2026, 04:36 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Mar 09, 2026 | Gift | - | 20,000 | - | 906,556 | Mar 11, 2026, 05:41 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Mar 09, 2026 | Conversion | - | 20,000 | - | 926,556 | Mar 11, 2026, 05:41 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Feb 17, 2026 | Tax Payment (Shares) | $3.49 | 27,265 | 95,155 | 906,556 | Feb 19, 2026, 07:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Feb 19, 2026 | Conversion | - | 40,000 | - | 946,556 | Feb 19, 2026, 07:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Feb 19, 2026 | Sale | $3.46 | 40,000 | 138,400 | 906,556 | Feb 19, 2026, 07:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Feb 06, 2026 | Tax Payment (Shares) | $3.56 | 10,364 | 36,896 | 933,821 | Feb 06, 2026, 05:53 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Feb 04, 2026 | Conversion | - | 40,000 | - | 953,839 | Feb 06, 2026, 05:53 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Feb 04, 2026 | Sale | $4.12 | 40,000 | 164,800 | 913,839 | Feb 06, 2026, 05:53 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Jan 20, 2026 | Conversion | - | 40,000 | - | 953,839 | Jan 22, 2026, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Jan 20, 2026 | Sale | $4.47 | 40,000 | 178,800 | 913,839 | Jan 22, 2026, 07:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Jan 05, 2026 | Gift | - | 20,000 | - | 913,839 | Jan 07, 2026, 05:04 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Jan 05, 2026 | Sale | $4.25 | 40,000 | 170,000 | 933,839 | Jan 07, 2026, 05:04 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Director | Jan 05, 2026 | Conversion | - | 60,000 | - | 973,839 | Jan 07, 2026, 05:04 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 19, 2025 | Conversion | - | 40,000 | - | 953,839 | Dec 19, 2025, 05:04 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 19, 2025 | Sale | $4.50 | 40,000 | 180,000 | 913,839 | Dec 19, 2025, 05:04 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 04, 2025 | Gift | - | 20,000 | - | 913,839 | Dec 05, 2025, 07:20 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 04, 2025 | Sale | $4.63 | 40,000 | 185,200 | 933,839 | Dec 05, 2025, 07:20 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 04, 2025 | Conversion | - | 60,000 | - | 973,839 | Dec 05, 2025, 07:20 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 17, 2025 | Tax Payment (Shares) | $4.14 | 40,390 | 167,215 | 913,839 | Nov 19, 2025, 07:37 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 19, 2025 | Conversion | - | 40,000 | - | 953,839 | Nov 19, 2025, 07:37 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 19, 2025 | Sale | $4.16 | 40,000 | 166,400 | 913,839 | Nov 19, 2025, 07:37 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 04, 2025 | Sale | $5.21 | 40,000 | 208,400 | 974,229 | Nov 06, 2025, 04:23 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 04, 2025 | Conversion | - | 60,000 | - | 1,014,229 | Nov 06, 2025, 04:23 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 04, 2025 | Gift | - | 20,000 | - | 954,229 | Nov 06, 2025, 04:23 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 23, 2025 | Conversion | - | 100,000 | - | 1,054,229 | Oct 24, 2025, 06:49 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 23, 2025 | Sale | $5.70 | 100,000 | 570,000 | 954,229 | Oct 24, 2025, 06:49 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 10, 2025 | Gift | - | 20,000 | - | 954,229 | Oct 10, 2025, 06:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 10, 2025 | Sale | $6.04 | 100,000 | 604,000 | 974,229 | Oct 10, 2025, 06:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 10, 2025 | Conversion | - | 120,000 | - | 1,074,229 | Oct 10, 2025, 06:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 25, 2025 | Conversion | - | 100,000 | - | 1,054,229 | Sep 26, 2025, 06:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 25, 2025 | Sale | $4.76 | 100,000 | 476,000 | 954,229 | Sep 26, 2025, 06:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 10, 2025 | Gift | - | 20,000 | - | 954,229 | Sep 12, 2025, 04:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 10, 2025 | Sale | $4.71 | 100,000 | 471,000 | 974,229 | Sep 12, 2025, 04:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 10, 2025 | Conversion | - | 120,000 | - | 1,074,229 | Sep 12, 2025, 04:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 26, 2025 | Conversion | - | 100,000 | - | 1,054,229 | Aug 28, 2025, 08:00 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 26, 2025 | Sale | $4.84 | 100,000 | 484,000 | 954,229 | Aug 28, 2025, 08:00 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 15, 2025 | Tax Payment (Shares) | $5.64 | 40,390 | 227,800 | 954,229 | Aug 19, 2025, 06:22 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 11, 2025 | Conversion | - | 423,666 | - | 1,504,919 | Aug 13, 2025, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 11, 2025 | Sale | $5.28 | 100,000 | 528,000 | 0 | Aug 13, 2025, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 11, 2025 | Gift | - | 10,000 | - | 994,619 | Aug 13, 2025, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 11, 2025 | Sale | $5.28 | 500,300 | 2,641,584 | 1,004,619 | Aug 13, 2025, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 11, 2025 | Conversion | - | 17,875 | - | 17,875 | Aug 13, 2025, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 11, 2025 | Sale | $5.28 | 17,875 | 94,380 | 0 | Aug 13, 2025, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 11, 2025 | Conversion | - | 100,000 | - | 100,000 | Aug 13, 2025, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 15, 2025 | Tax Payment (Shares) | $4.25 | 36,197 | 153,837 | 1,081,253 | May 19, 2025, 04:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 27, 2025 | Sale | $6.04 | 138,574 | 836,987 | 1,117,450 | Mar 28, 2025, 04:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 06, 2025 | Conversion | - | 20,000 | - | 1,276,024 | Mar 07, 2025, 04:16 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 06, 2025 | Sale | $6.37 | 20,000 | 127,400 | 1,256,024 | Mar 07, 2025, 04:16 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 05, 2025 | Conversion | - | 20,000 | - | 1,276,024 | Mar 07, 2025, 04:16 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 05, 2025 | Sale | $6.58 | 20,000 | 131,600 | 1,256,024 | Mar 07, 2025, 04:16 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 18, 2025 | Tax Payment (Shares) | $10.64 | 17,132 | 182,284 | 1,256,024 | Feb 20, 2025, 04:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 05, 2025 | Sale | $7.68 | 20,000 | 153,600 | 1,273,156 | Feb 07, 2025, 04:14 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 06, 2025 | Conversion | - | 20,000 | - | 1,293,156 | Feb 07, 2025, 04:14 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 06, 2025 | Sale | $8.12 | 20,000 | 162,400 | 1,273,156 | Feb 07, 2025, 04:14 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 05, 2025 | Conversion | - | 20,000 | - | 1,293,156 | Feb 07, 2025, 04:14 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 03, 2025 | Tax Payment (Shares) | $7.25 | 5,569 | 40,375 | 1,273,156 | Feb 05, 2025, 04:50 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 08, 2025 | Sale | $7.31 | 20,000 | 146,200 | 736,633 | Jan 13, 2025, 05:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 10, 2025 | Conversion | - | 20,000 | - | 756,633 | Jan 13, 2025, 05:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 10, 2025 | Sale | $7.05 | 20,000 | 141,000 | 736,633 | Jan 13, 2025, 05:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 08, 2025 | Conversion | - | 20,000 | - | 756,633 | Jan 13, 2025, 05:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 04, 2024 | Conversion | - | 20,000 | - | 756,633 | Dec 06, 2024, 05:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 04, 2024 | Sale | $7.16 | 20,000 | 143,200 | 736,633 | Dec 06, 2024, 05:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 05, 2024 | Conversion | - | 20,000 | - | 756,633 | Dec 06, 2024, 05:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 05, 2024 | Sale | $7.12 | 20,000 | 142,400 | 736,633 | Dec 06, 2024, 05:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 15, 2024 | Tax Payment (Shares) | $6.18 | 26,023 | 160,692 | 736,633 | Nov 19, 2024, 06:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 13, 2024 | Conversion | - | 20,000 | - | 782,656 | Nov 15, 2024, 06:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 13, 2024 | Sale | $7.74 | 20,000 | 154,800 | 762,656 | Nov 15, 2024, 06:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 14, 2024 | Conversion | - | 20,000 | - | 782,656 | Nov 15, 2024, 06:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 14, 2024 | Sale | $7.35 | 20,000 | 147,000 | 762,656 | Nov 15, 2024, 06:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 03, 2024 | Sale | $6.08 | 20,000 | 121,600 | 762,656 | Oct 04, 2024, 06:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 02, 2024 | Conversion | - | 20,000 | - | 782,656 | Oct 04, 2024, 06:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 02, 2024 | Sale | $6.16 | 20,000 | 123,200 | 762,656 | Oct 04, 2024, 06:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 03, 2024 | Conversion | - | 20,000 | - | 782,656 | Oct 04, 2024, 06:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 05, 2024 | Conversion | - | 20,000 | - | 782,656 | Sep 06, 2024, 04:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 05, 2024 | Sale | $6.14 | 20,000 | 122,800 | 762,656 | Sep 06, 2024, 04:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 04, 2024 | Conversion | - | 20,000 | - | 782,656 | Sep 06, 2024, 04:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 04, 2024 | Sale | $6.04 | 20,000 | 120,800 | 762,656 | Sep 06, 2024, 04:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 30, 2024 | Option/RSU Exercise | $2.48 | 5,000 | 12,400 | 762,656 | Aug 30, 2024, 04:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 29, 2024 | Option/RSU Exercise | $2.48 | 5,000 | 12,400 | 757,656 | Aug 29, 2024, 04:22 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 28, 2024 | Option/RSU Exercise | $2.48 | 5,000 | 12,400 | 752,656 | Aug 28, 2024, 04:12 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 27, 2024 | Option/RSU Exercise | $2.48 | 5,000 | 12,400 | 747,656 | Aug 27, 2024, 04:10 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 26, 2024 | Option/RSU Exercise | $2.48 | 5,000 | 12,400 | 742,656 | Aug 26, 2024, 04:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 23, 2024 | Option/RSU Exercise | $2.48 | 5,000 | 12,400 | 737,656 | Aug 23, 2024, 05:25 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 15, 2024 | Tax Payment (Shares) | $6.69 | 26,082 | 174,489 | 732,656 | Aug 19, 2024, 07:09 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 08, 2024 | Conversion | - | 20,000 | - | 778,738 | Aug 09, 2024, 04:56 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 08, 2024 | Sale | $6.50 | 20,000 | 130,000 | 758,738 | Aug 09, 2024, 04:56 PM |